Drugs · Entity Annotation Prototype (beta)

5articles mentioning drugs

13drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

hs-cTnI

This drug is selected. Its supporting articles are shown below.

5 articles · page 1 of 1

bmjopen · abstract · 2026-04-17 · 5 matching annotations

79.9%

…ponin I (hs-cTnI) and N-terminal pro-brain natriuretic peptide (NT-proBNP) in predicting major adverse cardiovascular events (MACE) follo…

heartjnl · abstract · 2026-06-09 · 4 matching annotations

82.2%

…I) for all-cause mortality were significant for each biomarker: NT-proBNP 1.35 (1.26-1.44); hs-cTnT 1.75 (1.48-2.07); hs-cTnI 1.33 (1.24-…

heartjnl · abstract · 2025-08-26 · 2 matching annotations

79.6%

…d on a single low level of high-sensitivity cardiac troponin I (hs-cTnI) at presentation increases the proportion of patients presentin…

emermed · abstract · 2026-04-20 · 1 matching annotations

75.7%

…hs-cTnI assay (331.75 minutes, n=1,169) was used, compared with hs-cTnT (347.17 minutes, n=900) (p=0.02). For patients requiring two sa…

heartjnl · abstract · 2025-12-18 · 1 matching annotations

77.2%

…risk of LLD events over 14.5 years. These findings suggest that hs-cTnI may identify older women at higher risk of LLD, capturing both …